×
返回 Agenda
TOPIC 2 SESSION 8 CONTINUED: Audits and Inspections in Pharmacovigilance
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Audits and Inspections in Pharmacovigilance - Industry Perspective
Jonathan Rowell
Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom
Director Regulatory Compliance